BlackRock’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$189M Buy
5,234,106
+253,578
+5% +$8.52M ﹤0.01% 1834
2026
Q1
$179M Buy
4,980,528
+39,951
+0.8% +$1.03M ﹤0.01% 1747
2025
Q4
$98.2M Buy
4,940,577
+2,091
+0% +$40.2K ﹤0.01% 2121
2025
Q3
$90.1M Buy
4,938,486
+230,176
+5% +$3.79M ﹤0.01% 2165
2025
Q2
$74.2M Buy
4,708,310
+3,279,358
+229% +$41.7M ﹤0.01% 2236
2025
Q1
$18.1M Sell
1,428,952
-21,638
-1% -$340K ﹤0.01% 2996
2024
Q4
$31.9M Buy
1,450,590
+346,871
+31% +$7.29M ﹤0.01% 2748
2024
Q3
$19.7M Buy
+1,103,719
New +$17.7M ﹤0.01% 3057

Other funds holding CLMT

BlackRock's CLMT Position: Q2 2026 in Review

BlackRock increased its Calumet Specialty Products (CLMT) stake by 5.1% in Q2 2026, buying an estimated $8.52M and bringing the position to 5,234,106 shares worth $189M. The position accounts for ﹤0.01% of the portfolio, ranked #1834.

BlackRock first reported a position in CLMT in Q3 2024 and has held it in 8 quarters since. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • BlackRock held 5,234,106 shares of Calumet Specialty Products worth $189M as of Q2 2026.
  • BlackRock bought 253,578 Calumet Specialty Products shares in Q2 2026, an estimated $8.52M.
  • Calumet Specialty Products made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #1834 holding.
  • BlackRock first reported a position in Calumet Specialty Products in Q3 2024 and has held it in 8 quarters since.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.